시장보고서
상품코드
1768275

세계의 헬스케어 챗봇 시장 규모, 점유율, 업계 분석 보고서 : 컴포넌트별, 용도별, 전개 형태별, 최종 용도별, 지역별, 전망과 예측(2025-2032년)

Global Healthcare Chatbot Market Size, Share & Industry Analysis Report By Component, By Application, By Deployment, By End-use, By Regional Outlook and Forecast, 2025 - 2032

발행일: | 리서치사: KBV Research | 페이지 정보: 영문 363 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 헬스케어 챗봇 시장 규모는 예측 기간 중에 23.7%의 연평균 복합 성장률(CAGR)로 성장하여 2032년까지 62억 2,000만 달러에 이를 것으로 예상되고 있습니다.

코로나19 팬데믹으로 인해 전 세계 의료 시스템이 환자들의 엄청난 문의와 제한된 의료 자원으로 어려움을 겪고 있는 가운데, 헬스케어 챗봇의 도입이 눈에 띄게 가속화되었습니다. 봉쇄와 사회적 거리두기로 인해 대면 진료가 제한되는 상황에서 챗봇은 적시에 건강 정보, 증상 확인, 진료 안내를 원하는 환자들에게 필수적인 디지털 창구로 부상했습니다. 이처럼 코로나19 팬데믹은 챗봇 시장에 긍정적인 영향을 미쳤습니다.

시장 성장 요인

헬스케어 정보와 서비스에 대한 즉각적인 접근에 대한 기대가 높아지면서 헬스케어 챗봇의 도입이 가속화되고 있습니다. 오늘날 환자들은 기존의 진료 시간에 구애받지 않고 건강 관련 질문, 진료 예약, 복약 알림 등에 대한 실시간 답변을 원하고 있습니다. 첨단 AI와 자연어 처리 기능을 갖춘 헬스케어 챗봇은 24시간 지원을 제공하여 사용자가 언제든 신뢰할 수 있는 정보와 지원을 받을 수 있도록 합니다. 결론적으로, 24/7 헬스케어 서비스에 대한 수요는 이 시장 확대의 중요한 원동력이 되고 있습니다.

또한, 의료 서비스 제공에 따른 비용 상승으로 인해 의료 서비스 제공업체와 의료기관은 품질 저하 없이 비용을 절감할 수 있는 혁신적인 솔루션을 찾아야 하는 상황에 직면해 있습니다. 헬스케어 챗봇은 환자 접수, 예약 예약, 예비 진단과 같은 관리 업무를 자동화함으로써 비용 효율적인 대안을 제공합니다. 이러한 프로세스를 간소화함으로써 챗봇은 막대한 인적 자원의 필요성을 최소화하고 운영 비용을 절감합니다. 따라서 비용 효율적인 헬스케어 솔루션의 추구는 시장 성장을 견인하는 중요한 요소로 작용하고 있습니다.

시장 성장 억제요인

챗봇을 헬스케어 시스템에 통합하면 데이터 프라이버시 및 보안에 대한 심각한 문제가 발생합니다. 이러한 AI 기반 도구는 병력, 개인 식별 정보, 건강 관련 문의 등 환자의 기밀 정보를 다루는 경우가 많기 때문에 이러한 데이터의 기밀성과 무결성을 보장하는 것이 가장 중요합니다. 그러나 챗봇 시스템에는 악의적인 공격자가 악용할 수 있는 취약점이 있다는 연구 결과가 있습니다. 따라서 이러한 문제를 해결하기 위해서는 엄격한 데이터 보호 프로토콜의 구현, 정기적인 보안 감사, 그리고 데이터 처리의 투명성 확보가 필수적입니다.

가치사슬 분석

이 시장의 밸류체인 분석은 종합적인 개발 및 제공주기를 강조합니다. 먼저 연구개발(R&D)에서 시작하여 컨텐츠와 의료 지식을 챗봇 시스템에 통합합니다. 그 다음에는 플랫폼 개발 및 통합이 진행되어 기술 인프라를 구축합니다. 다음 단계에서는 사용자 경험(UX)과 인터페이스 설계에 집중하여 사용성을 개선하고, 규제 기준을 충족하기 위한 데이터 보안 및 컴플라이언스 관리와 규제 준수에 집중합니다. 이 프로세스는 마케팅과 고객 확보로 이어지며, 판매와 유통으로 이어집니다. 도입 후 단계에는 구현 및 맞춤 서비스, 모니터링 및 분석, 지속적인 유지보수 및 업그레이드가 포함되며, 최종적으로 R&D로 돌아가 지속적인 혁신으로 이어집니다.

시장 점유율 분석

컴포넌트 전망

구성 요소에 따라 시장은 소프트웨어 및 서비스로 분류됩니다. 소프트웨어에는 AI 알고리즘, NLP 엔진, 챗봇 인터페이스가 포함되며, 서비스에는 도입, 통합, 교육, 유지보수가 포함됩니다. 서비스 부문은 2024년 37%의 매출 점유율을 차지할 것으로 예측됩니다. 세계 시장에서 서비스는 원활한 구현과 장기적인 기능성을 보장하는 데 중요한 역할을 합니다. 여기에는 맞춤형 개발, 시스템 통합, API 관리, 봇의 효과적인 사용을 위한 직원 교육, 지속적인 분석 및 성능 최적화 제공 등이 포함됩니다.

용도 전망

유럽 헬스케어 챗봇 시장은 용도별로 의료 데이터 저장소, 자동 환자 지원, 개인 지원, 기타 용도로 분류됩니다. 자동 환자 지원 부문은 2024년 29%의 매출 점유율을 차지할 것으로 예측됩니다. 예약 관리, 검사 결과 전달, 증상 분류, 예방접종 알림과 같은 자동화된 챗봇 기능은 현재 전 세계적으로 널리 사용되고 있습니다. 이러한 기능은 24/7 셀프 서비스 옵션을 제공함으로써 관리 업무의 부담을 크게 줄이고 환자 만족도를 향상시킬 수 있습니다.

전개 전망

배포에 따라 헬스케어 챗봇 시장은 클라우드 모델과 On-Premise 모델로 분류되며, 각기 다른 운영 및 규제 요구 사항에 따라 분류됩니다. On-Premise 부문은 2024년 36%의 매출 점유율을 차지할 것으로 예측됩니다. On-Premise 구축은 데이터에 대한 완전한 제어가 요구되는 환경에서 여전히 중요합니다. 이 모델은 엄격한 데이터 레지던시, 프라이버시, 시스템 커스터마이징을 지원하며, 유럽과 같이 규제가 엄격한 지역의 기관, 정부 기관, 국방 기관 등 헬스케어 분야에서 선호되고 있습니다.

최종 용도 전망

헬스케어 챗봇 시장은 최종 사용자별로 의료 서비스 제공업체, 환자, 보험사, 기타 최종 사용자로 분류됩니다. 환자 부문은 2024년 22%의 매출 점유율을 차지할 것으로 예측됩니다. 전 세계 환자들은 모바일 챗봇 플랫폼을 통해 온디맨드 방식으로 의료 서비스를 이용할 수 있다는 이점을 누리고 있습니다. 만성질환 관리, 정신 건강 지원(Woebot, Wysa 등) 이용, 증상 해석 등 챗봇은 사용자가 스스로 건강을 관리할 수 있도록 돕습니다.

지역 전망

지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 구분됩니다. 유럽은 2024년 35.92% 시장 점유율을 기록했습니다. 이러한 성장은 헬스케어 서비스의 디지털화 진전과 이 지역의 인공지능 기술의 광범위한 도입에 기인합니다. 또한, 여러 주요 시장 기업의 존재, 강력한 의료 인프라, 환자 참여에 대한 관심이 높아지면서 헬스케어 챗봇의 도입이 더욱 가속화되고 있습니다.

목차

제1장 시장 범위와 조사 방법

  • 시장의 정의
  • 목적
  • 시장 범위
  • 세분화
  • 조사 방법

제2장 시장 개관

  • 주요 하이라이트

제3장 시장 개요

  • 서론
    • 개요
  • 시장에 영향을 미치는 주요 요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 시장 기회
    • 시장이 해결해야 할 과제

제4장 경쟁 분석 - 세계

  • 시장 점유율 분석, 2024년
  • Porter의 Five Forces 분석

제5장 헬스케어 챗봇 시장 밸류체인 분석

  • 연구개발(R&D)
  • 컨텐츠 및 의학 지식 통합
  • 플랫폼 개발과 통합
  • 사용자 경험(UX) 및 인터페이스 디자인
  • 데이터 보안 및 컴플라이언스 관리
  • 마케팅 및 고객 획득
  • 판매 및 유통
  • 구현 및 커스터마이즈 서비스
  • 모니터링 및 분석
  • 유지관리 및 업그레이드

제6장 세계 시장의 주요 고객 기준

  • 정확성과 의학적 신뢰성
  • 데이터 프라이버시와 컴플라이언스
  • 통합 기능
  • 다언어/다문화 적응력
  • 비용 효율과 ROI
  • 사용자 경험과 접근성

제7장 세계의 헬스케어 챗봇 시장 : 컴포넌트별

  • 세계의 소프트웨어 시장 : 지역별
  • 세계의 서비스 시장 : 지역별

제8장 세계의 헬스케어 챗봇 시장 : 용도별

  • 세계의 의료 데이터 리포지토리 시장 : 지역별
  • 세계의 자동 환자 지원 시장 : 지역별
  • 세계의 퍼스널 어시스턴스 시장 : 지역별
  • 세계의 기타 용도 시장 : 지역별

제9장 세계의 헬스케어 챗봇 시장 : 전개 형태별

  • 세계의 클라우드 시장 : 지역별
  • 세계의 On-Premise 시장 : 지역별

제10장 세계의 헬스케어 챗봇 시장 : 최종 용도별

  • 세계의 의료 제공자 시장 : 지역별
  • 세계의 환자 시장 : 지역별
  • 세계의 보험회사 시장 : 지역별
  • 세계의 기타 최종 용도 시장 : 지역별

제11장 세계의 헬스케어 챗봇 시장 : 지역별

  • 북미
    • 북미의 헬스케어 챗봇 시장 : 국가별
      • 미국
      • 캐나다
      • 멕시코
      • 기타 북미
  • 유럽
    • 유럽의 헬스케어 챗봇 시장 : 국가별
      • 독일
      • 영국
      • 프랑스
      • 러시아
      • 스페인
      • 이탈리아
      • 기타 유럽
  • 아시아태평양
    • 아시아태평양의 헬스케어 챗봇 시장 : 국가별
      • 중국
      • 일본
      • 인도
      • 한국
      • 싱가포르
      • 말레이시아
      • 기타 아시아태평양
  • 라틴아메리카, 중동 및 아프리카
    • 라틴아메리카, 중동 및 아프리카의 헬스케어 챗봇 시장 : 국가별
      • 브라질
      • 아르헨티나
      • 아랍에미리트(UAE)
      • 사우디아라비아
      • 남아프리카공화국
      • 나이지리아
      • 기타 라틴아메리카, 중동 및 아프리카

제12장 기업 개요

  • Ada Health GmbH
  • Healthily LTD
  • Babylon Healthcare Services Ltd(eMed)
  • Woebot Labs, Inc(Woebot Health)
  • TECKEL MEDICAL SL.(Mediktor)
  • HealthTap, Inc
  • Luka, Inc(Replika)
  • K Health, Inc
  • BytePlus Pte Ltd
  • Fabric Labs, Inc(Fabric)

제13장 헬스케어 챗봇 시장을 위한 성공 필수 조건

LSH 25.07.21

The Global Healthcare Chatbot Market size is expected to reach $6.22 billion by 2032, rising at a market growth of 23.7% CAGR during the forecast period.

These platforms are widely used across the U.S., UK, China, and India, where chatbot implementation supports both patient-facing and internal healthcare operations. Cloud-based models dominate the software segment globally due to their scalability and rapid deployment capabilities.

COVID 19 Impact Analysis

The COVID-19 pandemic significantly accelerated the adoption of healthcare chatbots as healthcare systems worldwide grappled with overwhelming patient inquiries and limited medical resources. As lockdowns and social distancing mandates disrupted in-person consultations, chatbots emerged as an essential digital front door for patients seeking timely health information, symptom checks, and care guidance. Thus, the COVID-19 pandemic had a positive impact on the market.

Market Growth Factors

The increasing expectation for immediate access to healthcare information and services has significantly fueled the adoption of healthcare chatbots. Patients today seek real-time responses to their health-related queries, appointment scheduling, and medication reminders without the constraints of traditional office hours. Healthcare chatbots, powered by advanced AI and natural language processing, provide round-the-clock assistance, ensuring that users can access reliable information and support at any time. In conclusion, the demand for 24/7 healthcare services continues to be a significant driver in the expansion of this market.

Additionally, the escalating costs associated with healthcare delivery have prompted providers and institutions to seek innovative solutions that can reduce expenses without compromising quality. Healthcare chatbots offer a cost-effective alternative by automating administrative tasks such as patient intake, appointment scheduling, and preliminary diagnostics. By streamlining these processes, chatbots minimize the need for extensive human resources, thereby lowering operational costs. Hence, Consequently, the pursuit of cost-effective healthcare solutions remains a pivotal factor driving the growth of the market.

Market Restraining Factors

The integration of chatbots into healthcare systems introduces significant challenges related to data privacy and security. These AI-driven tools often handle sensitive patient information, including medical histories, personal identifiers, and health-related queries. Ensuring the confidentiality and integrity of this data is paramount. However, studies have highlighted vulnerabilities in chatbot systems that could be exploited by malicious actors. Therefore, addressing these concerns requires implementing stringent data protection protocols, regular security audits, and ensuring transparency in data handling practices.

Value Chain Analysis

The value chain analysis of this Market highlights a comprehensive development and delivery cycle. It begins with Research & Development (R&D), followed by content and medical knowledge integration into the chatbot system. This is succeeded by platform development and integration, ensuring technical infrastructure readiness. The next stage focuses on user experience (UX) and interface design to enhance usability, along with data security and compliance management to meet regulatory standards. The process continues with marketing and customer acquisition, supported by sales and distribution. Post-deployment stages include implementation and customization services, monitoring and analytics, and continuous maintenance and upgrades, looping back into R&D for ongoing innovation.

Market Share Analysis

Component Outlook

Based on Component, the Market is segmented into Software and Services, where software includes AI algorithms, NLP engines, and chatbot interfaces, and services encompass deployment, integration, training, and maintenance. The Services segment acquired 37% revenue share in 2024. Services in the global market play a pivotal role in ensuring seamless implementation and long-term functionality. These include custom development, systems integration, API management, training staff to use bots effectively, and offering ongoing analytics and performance optimization.

Application Outlook

Based on Application, the Healthcare Chatbot Market in Europe is segmented into Medical Data Repositories, Automated Patient Support, Personal Assistance, and Other Applications. Automated Patient Support segment attained 29% revenue share in 2024. Automated chatbot functions such as appointment scheduling, test result delivery, symptom triage, and vaccination reminders are now widespread globally. They significantly reduce administrative workloads and improve patient satisfaction by offering 24/7 self-service options.

Deployment Outlook

Based on Deployment, the Global Healthcare Chatbot Market is segmented into Cloud and On-Premises models, each catering to different operational and regulatory needs. The On-premises segment acquired 36% revenue share in 2024. On-premises deployment remains crucial in environments requiring full control over data. Often preferred by institutions in highly regulated regions like Europe, and in government or defense healthcare settings, this model supports strict data residency, privacy, and system customization.

End-use Outlook

Based on End Use, the Healthcare Chatbot Market is segmented into Healthcare Providers, Patients, Insurance Companies, and Other End Users. The Patients segment witnessed 22% revenue share in 2024. Patients across continents benefit from on-demand access to healthcare services through mobile chatbot platforms. Whether managing chronic diseases, accessing mental health support (e.g., Woebot, Wysa), or interpreting symptoms, chatbots empower users to take control of their health.

Regional Outlook

Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA. The Europe segment recorded 35.92% revenue share in the market in 2024. This growth can be attributed to the increasing digitalization of healthcare services and the widespread adoption of artificial intelligence technologies within the region. In addition, the presence of several key market players, strong healthcare infrastructure, and a growing emphasis on patient engagement have further fueled the adoption of healthcare chatbots.

List of Key Companies Profiled

  • Ada Health GmbH
  • Healthily LTD.
  • Babylon Healthcare Services Ltd. (eMed)
  • Woebot Labs, Inc. (Woebot Health)
  • TECKEL MEDICAL S.L. (Mediktor)
  • HealthTap, Inc.
  • Luka, Inc. (Replika)
  • K Health, Inc.
  • BytePlus Pte Ltd.
  • Fabric Labs, Inc. (Fabric)

Global Healthcare Chatbot Market Report Segmentation

By Component

  • Software
  • Services

By Application

  • Medical Data Repositories
  • Automated patient support
  • Personal Assistance
  • Other Application

By Deployment

  • Cloud
  • On-Premises

By End-use

  • Healthcare providers
  • Patients
  • Insurance companies
  • Other End-use

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Healthcare Chatbot Market, by Component
    • 1.4.2 Global Healthcare Chatbot Market, by Application
    • 1.4.3 Global Healthcare Chatbot Market, by Deployment
    • 1.4.4 Global Healthcare Chatbot Market, by End-use
    • 1.4.5 Global Healthcare Chatbot Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

  • 4.1 Market Share Analysis, 2024
  • 4.2 Porter Five Forces Analysis

Chapter 5. Value Chain Analysis of Healthcare Chatbot Market

  • 5.1 Research & Development (R&D)
  • 5.2 Content and Medical Knowledge Integration
  • 5.3 Platform Development and Integration
  • 5.4 User Experience (UX) and Interface Design
  • 5.5 Data Security and Compliance Management
  • 5.6 Marketing and Customer Acquisition
  • 5.7 Sales and Distribution
  • 5.8 Implementation and Customization Services
  • 5.9 Monitoring and Analytics
  • 5.10. Maintenance and Upgrades

Chapter 6. Key Customer Criteria of Global Healthcare Chatbot Market

  • 6.1 Accuracy and Medical Reliability
  • 6.2 Data Privacy and Compliance
  • 6.3 Integration Capabilities
  • 6.4 Multilingual and Cultural Adaptability
  • 6.5 Cost Efficiency and ROI
  • 6.6 User Experience and Accessibility

Chapter 7. Global Healthcare Chatbot Market by Component

  • 7.1 Global Software Market by Region
  • 7.2 Global Services Market by Region

Chapter 8. Global Healthcare Chatbot Market by Application

  • 8.1 Global Medical Data Repositories Market by Region
  • 8.2 Global Automated patient support Market by Region
  • 8.3 Global Personal Assistance Market by Region
  • 8.4 Global Other Application Market by Region

Chapter 9. Global Healthcare Chatbot Market by Deployment

  • 9.1 Global Cloud Market by Region
  • 9.2 Global On-Premises Market by Region

Chapter 10. Global Healthcare Chatbot Market by End-use

  • 10.1 Global Healthcare providers Market by Region
  • 10.2 Global Patients Market by Region
  • 10.3 Global Insurance companies Market by Region
  • 10.4 Global Other End-use Market by Region

Chapter 11. Global Healthcare Chatbot Market by Region

  • 11.1 North America Healthcare Chatbot Market
    • 11.1.1 North America Healthcare Chatbot Market by Component
      • 11.1.1.1 North America Software Market by Region
      • 11.1.1.2 North America Services Market by Region
    • 11.1.2 North America Healthcare Chatbot Market by Application
      • 11.1.2.1 North America Medical Data Repositories Market by Country
      • 11.1.2.2 North America Automated patient support Market by Country
      • 11.1.2.3 North America Personal Assistance Market by Country
      • 11.1.2.4 North America Other Application Market by Country
    • 11.1.3 North America Healthcare Chatbot Market by Deployment
      • 11.1.3.1 North America Cloud Market by Country
      • 11.1.3.2 North America On-Premises Market by Country
    • 11.1.4 North America Healthcare Chatbot Market by End-use
      • 11.1.4.1 North America Healthcare providers Market by Country
      • 11.1.4.2 North America Patients Market by Country
      • 11.1.4.3 North America Insurance companies Market by Country
      • 11.1.4.4 North America Other End-use Market by Country
    • 11.1.5 North America Healthcare Chatbot Market by Country
      • 11.1.5.1 US Healthcare Chatbot Market
        • 11.1.5.1.1 US Healthcare Chatbot Market by Component
        • 11.1.5.1.2 US Healthcare Chatbot Market by Application
        • 11.1.5.1.3 US Healthcare Chatbot Market by Deployment
        • 11.1.5.1.4 US Healthcare Chatbot Market by End-use
      • 11.1.5.2 Canada Healthcare Chatbot Market
        • 11.1.5.2.1 Canada Healthcare Chatbot Market by Component
        • 11.1.5.2.2 Canada Healthcare Chatbot Market by Application
        • 11.1.5.2.3 Canada Healthcare Chatbot Market by Deployment
        • 11.1.5.2.4 Canada Healthcare Chatbot Market by End-use
      • 11.1.5.3 Mexico Healthcare Chatbot Market
        • 11.1.5.3.1 Mexico Healthcare Chatbot Market by Component
        • 11.1.5.3.2 Mexico Healthcare Chatbot Market by Application
        • 11.1.5.3.3 Mexico Healthcare Chatbot Market by Deployment
        • 11.1.5.3.4 Mexico Healthcare Chatbot Market by End-use
      • 11.1.5.4 Rest of North America Healthcare Chatbot Market
        • 11.1.5.4.1 Rest of North America Healthcare Chatbot Market by Component
        • 11.1.5.4.2 Rest of North America Healthcare Chatbot Market by Application
        • 11.1.5.4.3 Rest of North America Healthcare Chatbot Market by Deployment
        • 11.1.5.4.4 Rest of North America Healthcare Chatbot Market by End-use
  • 11.2 Europe Healthcare Chatbot Market
    • 11.2.1 Europe Healthcare Chatbot Market by Component
      • 11.2.1.1 Europe Software Market by Country
      • 11.2.1.2 Europe Services Market by Country
    • 11.2.2 Europe Healthcare Chatbot Market by Application
      • 11.2.2.1 Europe Medical Data Repositories Market by Country
      • 11.2.2.2 Europe Automated patient support Market by Country
      • 11.2.2.3 Europe Personal Assistance Market by Country
      • 11.2.2.4 Europe Other Application Market by Country
    • 11.2.3 Europe Healthcare Chatbot Market by Deployment
      • 11.2.3.1 Europe Cloud Market by Country
      • 11.2.3.2 Europe On-Premises Market by Country
    • 11.2.4 Europe Healthcare Chatbot Market by End-use
      • 11.2.4.1 Europe Healthcare providers Market by Country
      • 11.2.4.2 Europe Patients Market by Country
      • 11.2.4.3 Europe Insurance companies Market by Country
      • 11.2.4.4 Europe Other End-use Market by Country
    • 11.2.5 Europe Healthcare Chatbot Market by Country
      • 11.2.5.1 Germany Healthcare Chatbot Market
        • 11.2.5.1.1 Germany Healthcare Chatbot Market by Component
        • 11.2.5.1.2 Germany Healthcare Chatbot Market by Application
        • 11.2.5.1.3 Germany Healthcare Chatbot Market by Deployment
        • 11.2.5.1.4 Germany Healthcare Chatbot Market by End-use
      • 11.2.5.2 UK Healthcare Chatbot Market
        • 11.2.5.2.1 UK Healthcare Chatbot Market by Component
        • 11.2.5.2.2 UK Healthcare Chatbot Market by Application
        • 11.2.5.2.3 UK Healthcare Chatbot Market by Deployment
        • 11.2.5.2.4 UK Healthcare Chatbot Market by End-use
      • 11.2.5.3 France Healthcare Chatbot Market
        • 11.2.5.3.1 France Healthcare Chatbot Market by Component
        • 11.2.5.3.2 France Healthcare Chatbot Market by Application
        • 11.2.5.3.3 France Healthcare Chatbot Market by Deployment
        • 11.2.5.3.4 France Healthcare Chatbot Market by End-use
      • 11.2.5.4 Russia Healthcare Chatbot Market
        • 11.2.5.4.1 Russia Healthcare Chatbot Market by Component
        • 11.2.5.4.2 Russia Healthcare Chatbot Market by Application
        • 11.2.5.4.3 Russia Healthcare Chatbot Market by Deployment
        • 11.2.5.4.4 Russia Healthcare Chatbot Market by End-use
      • 11.2.5.5 Spain Healthcare Chatbot Market
        • 11.2.5.5.1 Spain Healthcare Chatbot Market by Component
        • 11.2.5.5.2 Spain Healthcare Chatbot Market by Application
        • 11.2.5.5.3 Spain Healthcare Chatbot Market by Deployment
        • 11.2.5.5.4 Spain Healthcare Chatbot Market by End-use
      • 11.2.5.6 Italy Healthcare Chatbot Market
        • 11.2.5.6.1 Italy Healthcare Chatbot Market by Component
        • 11.2.5.6.2 Italy Healthcare Chatbot Market by Application
        • 11.2.5.6.3 Italy Healthcare Chatbot Market by Deployment
        • 11.2.5.6.4 Italy Healthcare Chatbot Market by End-use
      • 11.2.5.7 Rest of Europe Healthcare Chatbot Market
        • 11.2.5.7.1 Rest of Europe Healthcare Chatbot Market by Component
        • 11.2.5.7.2 Rest of Europe Healthcare Chatbot Market by Application
        • 11.2.5.7.3 Rest of Europe Healthcare Chatbot Market by Deployment
        • 11.2.5.7.4 Rest of Europe Healthcare Chatbot Market by End-use
  • 11.3 Asia Pacific Healthcare Chatbot Market
    • 11.3.1 Asia Pacific Healthcare Chatbot Market by Component
      • 11.3.1.1 Asia Pacific Software Market by Country
      • 11.3.1.2 Asia Pacific Services Market by Country
    • 11.3.2 Asia Pacific Healthcare Chatbot Market by Application
      • 11.3.2.1 Asia Pacific Medical Data Repositories Market by Country
      • 11.3.2.2 Asia Pacific Automated patient support Market by Country
      • 11.3.2.3 Asia Pacific Personal Assistance Market by Country
      • 11.3.2.4 Asia Pacific Other Application Market by Country
    • 11.3.3 Asia Pacific Healthcare Chatbot Market by Deployment
      • 11.3.3.1 Asia Pacific Cloud Market by Country
      • 11.3.3.2 Asia Pacific On-Premises Market by Country
    • 11.3.4 Asia Pacific Healthcare Chatbot Market by End-use
      • 11.3.4.1 Asia Pacific Healthcare providers Market by Country
      • 11.3.4.2 Asia Pacific Patients Market by Country
      • 11.3.4.3 Asia Pacific Insurance companies Market by Country
      • 11.3.4.4 Asia Pacific Other End-use Market by Country
    • 11.3.5 Asia Pacific Healthcare Chatbot Market by Country
      • 11.3.5.1 China Healthcare Chatbot Market
        • 11.3.5.1.1 China Healthcare Chatbot Market by Component
        • 11.3.5.1.2 China Healthcare Chatbot Market by Application
        • 11.3.5.1.3 China Healthcare Chatbot Market by Deployment
        • 11.3.5.1.4 China Healthcare Chatbot Market by End-use
      • 11.3.5.2 Japan Healthcare Chatbot Market
        • 11.3.5.2.1 Japan Healthcare Chatbot Market by Component
        • 11.3.5.2.2 Japan Healthcare Chatbot Market by Application
        • 11.3.5.2.3 Japan Healthcare Chatbot Market by Deployment
        • 11.3.5.2.4 Japan Healthcare Chatbot Market by End-use
      • 11.3.5.3 India Healthcare Chatbot Market
        • 11.3.5.3.1 India Healthcare Chatbot Market by Component
        • 11.3.5.3.2 India Healthcare Chatbot Market by Application
        • 11.3.5.3.3 India Healthcare Chatbot Market by Deployment
        • 11.3.5.3.4 India Healthcare Chatbot Market by End-use
      • 11.3.5.4 South Korea Healthcare Chatbot Market
        • 11.3.5.4.1 South Korea Healthcare Chatbot Market by Component
        • 11.3.5.4.2 South Korea Healthcare Chatbot Market by Application
        • 11.3.5.4.3 South Korea Healthcare Chatbot Market by Deployment
        • 11.3.5.4.4 South Korea Healthcare Chatbot Market by End-use
      • 11.3.5.5 Singapore Healthcare Chatbot Market
        • 11.3.5.5.1 Singapore Healthcare Chatbot Market by Component
        • 11.3.5.5.2 Singapore Healthcare Chatbot Market by Application
        • 11.3.5.5.3 Singapore Healthcare Chatbot Market by Deployment
        • 11.3.5.5.4 Singapore Healthcare Chatbot Market by End-use
      • 11.3.5.6 Malaysia Healthcare Chatbot Market
        • 11.3.5.6.1 Malaysia Healthcare Chatbot Market by Component
        • 11.3.5.6.2 Malaysia Healthcare Chatbot Market by Application
        • 11.3.5.6.3 Malaysia Healthcare Chatbot Market by Deployment
        • 11.3.5.6.4 Malaysia Healthcare Chatbot Market by End-use
      • 11.3.5.7 Rest of Asia Pacific Healthcare Chatbot Market
        • 11.3.5.7.1 Rest of Asia Pacific Healthcare Chatbot Market by Component
        • 11.3.5.7.2 Rest of Asia Pacific Healthcare Chatbot Market by Application
        • 11.3.5.7.3 Rest of Asia Pacific Healthcare Chatbot Market by Deployment
        • 11.3.5.7.4 Rest of Asia Pacific Healthcare Chatbot Market by End-use
  • 11.4 LAMEA Healthcare Chatbot Market
    • 11.4.1 LAMEA Healthcare Chatbot Market by Component
      • 11.4.1.1 LAMEA Software Market by Country
      • 11.4.1.2 LAMEA Services Market by Country
    • 11.4.2 LAMEA Healthcare Chatbot Market by Application
      • 11.4.2.1 LAMEA Medical Data Repositories Market by Country
      • 11.4.2.2 LAMEA Automated patient support Market by Country
      • 11.4.2.3 LAMEA Personal Assistance Market by Country
      • 11.4.2.4 LAMEA Other Application Market by Country
    • 11.4.3 LAMEA Healthcare Chatbot Market by Deployment
      • 11.4.3.1 LAMEA Cloud Market by Country
      • 11.4.3.2 LAMEA On-Premises Market by Country
    • 11.4.4 LAMEA Healthcare Chatbot Market by End-use
      • 11.4.4.1 LAMEA Healthcare providers Market by Country
      • 11.4.4.2 LAMEA Patients Market by Country
      • 11.4.4.3 LAMEA Insurance companies Market by Country
      • 11.4.4.4 LAMEA Other End-use Market by Country
    • 11.4.5 LAMEA Healthcare Chatbot Market by Country
      • 11.4.5.1 Brazil Healthcare Chatbot Market
        • 11.4.5.1.1 Brazil Healthcare Chatbot Market by Component
        • 11.4.5.1.2 Brazil Healthcare Chatbot Market by Application
        • 11.4.5.1.3 Brazil Healthcare Chatbot Market by Deployment
        • 11.4.5.1.4 Brazil Healthcare Chatbot Market by End-use
      • 11.4.5.2 Argentina Healthcare Chatbot Market
        • 11.4.5.2.1 Argentina Healthcare Chatbot Market by Component
        • 11.4.5.2.2 Argentina Healthcare Chatbot Market by Application
        • 11.4.5.2.3 Argentina Healthcare Chatbot Market by Deployment
        • 11.4.5.2.4 Argentina Healthcare Chatbot Market by End-use
      • 11.4.5.3 UAE Healthcare Chatbot Market
        • 11.4.5.3.1 UAE Healthcare Chatbot Market by Component
        • 11.4.5.3.2 UAE Healthcare Chatbot Market by Application
        • 11.4.5.3.3 UAE Healthcare Chatbot Market by Deployment
        • 11.4.5.3.4 UAE Healthcare Chatbot Market by End-use
      • 11.4.5.4 Saudi Arabia Healthcare Chatbot Market
        • 11.4.5.4.1 Saudi Arabia Healthcare Chatbot Market by Component
        • 11.4.5.4.2 Saudi Arabia Healthcare Chatbot Market by Application
        • 11.4.5.4.3 Saudi Arabia Healthcare Chatbot Market by Deployment
        • 11.4.5.4.4 Saudi Arabia Healthcare Chatbot Market by End-use
      • 11.4.5.5 South Africa Healthcare Chatbot Market
        • 11.4.5.5.1 South Africa Healthcare Chatbot Market by Component
        • 11.4.5.5.2 South Africa Healthcare Chatbot Market by Application
        • 11.4.5.5.3 South Africa Healthcare Chatbot Market by Deployment
        • 11.4.5.5.4 South Africa Healthcare Chatbot Market by End-use
      • 11.4.5.6 Nigeria Healthcare Chatbot Market
        • 11.4.5.6.1 Nigeria Healthcare Chatbot Market by Component
        • 11.4.5.6.2 Nigeria Healthcare Chatbot Market by Application
        • 11.4.5.6.3 Nigeria Healthcare Chatbot Market by Deployment
        • 11.4.5.6.4 Nigeria Healthcare Chatbot Market by End-use
      • 11.4.5.7 Rest of LAMEA Healthcare Chatbot Market
        • 11.4.5.7.1 Rest of LAMEA Healthcare Chatbot Market by Component
        • 11.4.5.7.2 Rest of LAMEA Healthcare Chatbot Market by Application
        • 11.4.5.7.3 Rest of LAMEA Healthcare Chatbot Market by Deployment
        • 11.4.5.7.4 Rest of LAMEA Healthcare Chatbot Market by End-use

Chapter 12. Company Profiles

  • 12.1 Ada Health GmbH
    • 12.1.1 Company Overview
    • 12.1.2 Recent strategies and developments:
      • 12.1.2.1 Product Launches and Product Expansions:
  • 12.2 Healthily LTD.
    • 12.2.1 Company Overview
  • 12.3 Babylon Healthcare Services Ltd. (eMed)
    • 12.3.1 Company Overview
    • 12.3.2 Recent strategies and developments:
      • 12.3.2.1 Product Launches and Product Expansions:
  • 12.4 Woebot Labs, Inc. (Woebot Health)
    • 12.4.1 Company Overview
  • 12.5 TECKEL MEDICAL S.L. (Mediktor)
    • 12.5.1 Company Overview
  • 12.6 HealthTap, Inc.
    • 12.6.1 Company Overview
    • 12.6.2 Recent strategies and developments:
      • 12.6.2.1 Product Launches and Product Expansions:
  • 12.7 Luka, Inc. (Replika)
    • 12.7.1 Company Overview
  • 12.8 K Health, Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Recent strategies and developments:
      • 12.8.2.1 Product Launches and Product Expansions:
  • 12.9 BytePlus Pte Ltd.
    • 12.9.1 Company Overview
  • 12.10. Fabric Labs, Inc. (Fabric)
    • 12.10.1 Company Overview

Chapter 13. Winning Imperatives of Healthcare Chatbot Market

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제